Eiko Lifesciences Ltd

BSE: 540204 · Chemicals & Petrochemicals · 3 announcements

Share price: ₹51.22
Market cap: ₹70.28 Cr
Revenue (annual): ₹52.57 Cr
Net profit (annual): ₹4.50 Cr
P/E (TTM): 14.4×Sector 37.5×
Promoter holding: 39.91%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

22 Sep 2026 18:54 IST BSE

Annual General Meeting

Eiko Lifesciences Annual General Meeting

Eiko LifeSciences held its 49th Annual General Meeting on September 22, 2026. The meeting transacted business, including adoption of financial statements and appointment of directors.

Read the filing ↗

12 Aug 2026 13:49 IST BSE

Financial Results

Eiko Lifesciences Q1 FY27 Results: Net Profit ₹1.5 Cr, Up 36.4% YoY

Eiko Lifesciences Ltd reported revenue from operations of ₹16.7 Cr (+56.1% YoY) and net profit of ₹1.5 Cr (+36.4% YoY) for Q1 FY27.

Key figure: Net profit ₹1.5 Cr · +36.4% YoY

Open full results → Read the filing ↗

26 May 2026 13:28 IST BSE

Financial Results

Eiko Lifesciences Q4 FY26 Results: Net Profit ₹1.5 Cr, Up 25.0% YoY

Eiko Lifesciences Ltd reported revenue from operations of ₹18.3 Cr (+61.9% YoY) and net profit of ₹1.5 Cr (+25.0% YoY) for Q4 FY26.

Key figure: Net profit ₹1.5 Cr · +25.0% YoY

Open full results → Read the filing ↗